Laurence Baker, Ph.D., chief of Health Services Research and associate professor of health research and policy at Stanford University Medical School , is the principal investigator. Scott Atlas, M.D., professor of radiology and chief of neuroradiology at Stanford, and Christopher Afendulis, Ph.D., a lecturer in the Department of Health Care Policy at Harvard Medical School , are co-investigators.

Examining the Medical Device Commercialization Process


The device development study aims to examine how medical technology is brought to market, approved for use and subsequently enhanced over time. The team will build a model specific to medical technology, making clear distinctions from the drug development process. Researchers anticipate study findings will be of value to current and future government initiatives, such as the FDAs Critical Path Initiative to enhance the efficiency and efficacy of the regulatory process for public benefit.

Medical devices require a broader range of development cycles than drugs to achieve full commercialization. This distinction can be ambiguous but it has a significant impact on the timely availability of safe and effective technologies for patients and practitioners, Howgill said.

John Linehan, Ph.D., Consulting Professor of Bioengineering in Stanford University s Program in Biodesign and the Department of Bioengineering is the principal investigator. Elisabeth Pat-Cornell, Ph.D., co-investigator, is the Burt and Deedee McMurtry Professor of Engineering and Professor and Chair of the Department of Management Science and Engineering at Stanford University . Paul Yock, M.D., also a co- investigator, is the Martha Meier Weiland Professor of Medicine and Mechanical Engineering (by courtesy) and Co-Chair of Stanfords new Department of Bioengineering.

The two new Stanford University grants represent the most recent research awards from InHealth to support studies exploring the impact of innovative medical technology on socio-econmic issues including patient care, quality of life and cost efficiencies. InHealth-funded research is currently underway by teams at Duke University , Harvard University/Beth Israel Deaconness Medical Center and the University of Pennsylvania .

###

About InHealth (www.inhealth.org)
Launched in 2004, The Institute for Health Technology Studies (InHealth) is a 501(c) 3 nonprofit organization that researches the social and economic impact of medical technology. InHealth is funded by unrestricted philanthropic gifts and funds research grants and educational forums. It adheres to the International Committee of Medical Journal Editors principles of sponsorship.

Back to HCB News

More Industry Headlines